Nine researchers from FyFa receive funding from the Swedish Research Council
Congratulations to Igor Adameyko, Christopher Cederroth, Cristiana Cruceanu, Lars I Eriksson, Volker Lauschke, Jon Lundberg, Carl Sellgren, Camilla Svensson, and Eddie Weitzberg, researchers at the Department of Physiology and Pharmacology, on receiving grants from the Swedish Research Council's call in medicine and health for 2023. In total, 56.4 million has been awarded to the researchers at FyFa.
Roelinde Middelveld, research coordinator at FyFa, has been a support for the researchers in their application processes for grants from the Swedish Research Council. She sees several explanations for the success of the nine awardees.
"The primary reason is the high-quality research conducted at FyFa. For example, the consolidation grants and establishment grants are clear indications that the young researchers at the department are on the right path to establish themselves and their research projects. Given the intense competition, it is particularly gratifying that so many have succeeded in obtaining these grants," says Roelinde Middelveld.
Igor Adamayko
Igor Adameyko, research Group Leader for Developmental Biology and Regenerative Medicine at the Department of Physiology and Pharmacology receives 9 million for the period 2023-2027 for the research project "Analysis of multipotent neural stem cells".
Christopher Cederroth
Christopher Cederroth, research group leader for translational auditory neuroscience at the Department of Physiology and Pharmacology receives SEK 2.4 million for the period 2024-2026 for the research project "Targeting the cochlear powerhouse to treat hearing loss".
Cristiana Cruceanu
Cristiana Cruceanu, research Group Leader for Developmental and Translational Neurobiology at the Department of Physiology and Pharmacology receives 6 million SEK for the period 2024-2027 for the research project "The placenta as a mediator of the effects of psychological stress on neurodevelopmental reprogramming: lessons from human in vitro model systems".
Lars I Eriksson
Lars I Eriksson, professor and Head of Section in Anesthesiology and Intensive Care at the Department of Physiology and Pharmacology receives 7.2 million for the period 2023-2026 for the research project "Higher brain functions after surgery-trauma-induced neuroinflammation, cognitive impairment and dementia".
Volker Lauschke
Volker Lauschke research group leader for personalized medicine and drug development at the Department of Physiology and Pharmacology receives 7.4 million for the period 2024-2028 for the research project 'Modulation of tissue communication to combat non-alcoholic fatty liver disease'.
Jon Lundberg
Jon Lundberg, research group leader for pharmacological nitric oxide research at the Department of Physiology and Pharmacology, receives SEK 4.8 million for the period 2024-2027 for the research project 'New mechanisms for nitric oxide signaling in health and disease'.
Carl Sellgren
Carl Sellgren, research group leader for Cellular Modeling of Psychiatric Disorders at the Department of Physiology and Pharmacology, has been awarded 10 million SEK for the period 2024–2028 for the research project "Glia Cell Regulation of Synapse Density in Schizophrenia - Integrated Multimodal Experimental Clinical Studies with a Focus on Identifying New Target Structures."
Camilla Svensson
Camilla Svensson, research group leader for Molecular Pain Research at the Department of Physiology and Pharmacology has been awarded 4.8 million for the period 2024–2027 for the research project "Peripheral Pain Mechanisms in Fibromyalgia."
Eddie Weitzberg
Eddie Weitzberg, research group leader for the Nitrate-Nitrite-NO System in Disease and Health at the Department of Physiology and Pharmacology, has been awarded 4.8 million SEK for the period 2024–2027 for the research project "Nitric Oxide in Anesthesia and Intensive Care."